<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Neurocognitive Disorders - Domain 7: Biopsychology | MasteryPage</title>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <style>
    :root { --bg-primary: #09090b; --bg-secondary: #0f0f11; --bg-tertiary: #18181b; --bg-card: #1c1c1f; --text-primary: #fafafa; --text-secondary: #a1a1aa; --text-muted: #71717a; --accent: #ec4899; --accent-dim: rgba(236, 72, 153, 0.15); --border: rgba(255, 255, 255, 0.06); --border-light: rgba(255, 255, 255, 0.1); --gradient-gold: linear-gradient(135deg, #f59e0b 0%, #d97706 100%); --success: #22c55e; --success-dim: rgba(34, 197, 94, 0.15); --blue: #3b82f6; --blue-dim: rgba(59, 130, 246, 0.15); --radius-sm: 8px; --radius-md: 12px; --radius-lg: 16px; --font-display: 'Instrument Serif', Georgia, serif; --font-body: 'Inter', -apple-system, sans-serif; }
    * { margin: 0; padding: 0; box-sizing: border-box; } body { font-family: var(--font-body); background: var(--bg-primary); color: var(--text-primary); line-height: 1.7; }
    .top-nav { position: fixed; top: 0; left: 0; right: 0; height: 72px; background: rgba(9, 9, 11, 0.95); backdrop-filter: blur(20px); border-bottom: 1px solid var(--border); z-index: 1000; display: flex; align-items: center; padding: 0 32px; }
    .nav-left { display: flex; align-items: center; gap: 24px; } .logo { display: flex; align-items: center; gap: 10px; text-decoration: none; } .logo-icon { width: 36px; height: 36px; background: var(--gradient-gold); border-radius: 10px; display: flex; align-items: center; justify-content: center; } .logo-icon svg { width: 20px; height: 20px; color: var(--bg-primary); } .logo-text { font-family: var(--font-display); font-size: 1.35rem; color: var(--text-primary); }
    .breadcrumb { display: flex; align-items: center; gap: 8px; font-size: 0.9rem; color: var(--text-muted); } .breadcrumb a { color: var(--text-secondary); text-decoration: none; } .breadcrumb a:hover { color: var(--accent); } .breadcrumb svg { width: 16px; height: 16px; }
    .content-wrapper { padding-top: 72px; display: flex; min-height: 100vh; } .sidebar { width: 280px; background: var(--bg-secondary); border-right: 1px solid var(--border); position: fixed; top: 72px; bottom: 0; overflow-y: auto; padding: 24px 0; } .sidebar-header { padding: 0 20px 16px; border-bottom: 1px solid var(--border); margin-bottom: 16px; } .sidebar-title { font-size: 0.75rem; text-transform: uppercase; letter-spacing: 0.1em; color: var(--text-muted); margin-bottom: 8px; } .domain-title { font-size: 1rem; font-weight: 600; color: var(--accent); }
    .chapter-list { list-style: none; } .chapter-item { border-bottom: 1px solid var(--border); } .chapter-link { display: flex; align-items: center; gap: 12px; padding: 14px 20px; color: var(--text-secondary); text-decoration: none; font-size: 0.85rem; transition: all 0.2s ease; } .chapter-link:hover { background: var(--bg-tertiary); color: var(--text-primary); } .chapter-link.active { background: var(--accent-dim); color: var(--accent); border-left: 3px solid var(--accent); } .chapter-number { width: 24px; height: 24px; border-radius: 50%; background: var(--bg-tertiary); display: flex; align-items: center; justify-content: center; font-size: 0.75rem; font-weight: 600; flex-shrink: 0; }
    .main-content { margin-left: 280px; flex: 1; padding: 48px 64px; max-width: 900px; } .chapter-header { margin-bottom: 48px; } .chapter-badge { display: inline-flex; align-items: center; gap: 8px; padding: 6px 12px; background: var(--bg-tertiary); border: 1px solid var(--border); border-radius: 20px; font-size: 0.8rem; color: var(--text-muted); margin-bottom: 16px; }
    h1 { font-family: var(--font-display); font-size: 2.5rem; margin-bottom: 16px; line-height: 1.2; } .chapter-meta { display: flex; gap: 24px; color: var(--text-muted); font-size: 0.9rem; } .content-section { margin-bottom: 48px; }
    h2 { font-family: var(--font-display); font-size: 1.75rem; margin: 48px 0 20px; padding-bottom: 12px; border-bottom: 1px solid var(--border); } h2:first-of-type { margin-top: 0; } h3 { font-size: 1.25rem; font-weight: 600; margin: 32px 0 16px; color: var(--text-primary); }
    p { margin-bottom: 16px; color: var(--text-secondary); } ul, ol { margin: 16px 0; padding-left: 24px; color: var(--text-secondary); } li { margin-bottom: 8px; }
    .key-term { background: var(--accent-dim); color: var(--accent); padding: 2px 8px; border-radius: 4px; font-weight: 500; }
    .definition-box { background: var(--bg-card); border: 1px solid var(--border); border-radius: var(--radius-md); padding: 20px; margin: 24px 0; } .definition-box strong { color: var(--accent); } .definition-box p:last-child { margin-bottom: 0; }
    .example-box { background: var(--blue-dim); border: 1px solid rgba(59, 130, 246, 0.3); border-radius: var(--radius-md); padding: 20px; margin: 24px 0; } .example-box strong { color: var(--blue); } .example-box p:last-child { margin-bottom: 0; }
    .clinical-note { background: var(--success-dim); border: 1px solid rgba(34, 197, 94, 0.3); border-radius: var(--radius-md); padding: 20px; margin: 24px 0; } .clinical-note strong { color: var(--success); } .clinical-note p:last-child { margin-bottom: 0; }
    .citation { font-size: 0.85rem; color: var(--text-muted); padding: 16px; background: var(--bg-tertiary); border-left: 3px solid var(--accent); margin: 16px 0; border-radius: 0 var(--radius-sm) var(--radius-sm) 0; }
    table { width: 100%; border-collapse: collapse; margin: 24px 0; } th, td { padding: 12px 16px; text-align: left; border: 1px solid var(--border); } th { background: var(--bg-tertiary); font-weight: 600; color: var(--text-primary); } td { color: var(--text-secondary); }
    .nav-buttons { display: flex; justify-content: space-between; margin-top: 64px; padding-top: 32px; border-top: 1px solid var(--border); } .nav-btn { display: flex; align-items: center; gap: 12px; padding: 16px 24px; background: var(--bg-card); border: 1px solid var(--border); border-radius: var(--radius-md); text-decoration: none; color: var(--text-secondary); transition: all 0.2s ease; } .nav-btn:hover { border-color: var(--accent); color: var(--text-primary); } .nav-btn-label { font-size: 0.8rem; color: var(--text-muted); } .nav-btn-title { font-weight: 600; color: var(--text-primary); }
    @media (max-width: 1024px) { .sidebar { display: none; } .main-content { margin-left: 0; padding: 32px 24px; } }
    .chapter-actions { display: flex; gap: 12px; margin-bottom: 32px; flex-wrap: wrap; } .action-btn { display: inline-flex; align-items: center; gap: 8px; padding: 10px 20px; border-radius: 8px; font-size: 0.85rem; font-weight: 500; text-decoration: none; transition: all 0.2s ease; } .flashcard-btn { background: var(--bg-tertiary); border: 1px solid var(--border-light); color: var(--text-secondary); } .flashcard-btn:hover { background: var(--bg-card); color: var(--text-primary); border-color: var(--accent); } .quiz-btn { background: var(--bg-tertiary); border: 1px solid var(--border-light); color: var(--text-secondary); } .quiz-btn:hover { background: var(--bg-card); color: var(--text-primary); border-color: var(--accent); } .mastery-btn { background: linear-gradient(135deg, #f59e0b 0%, #ef4444 100%); border: none; color: #fff; font-weight: 600; box-shadow: 0 2px 12px rgba(245, 158, 11, 0.3); } .mastery-btn:hover { box-shadow: 0 4px 20px rgba(245, 158, 11, 0.5); transform: translateY(-1px); }
    .upgrade-modal-overlay { display:none; position:fixed; top:0; left:0; right:0; bottom:0; background:rgba(0,0,0,0.7); z-index:1000; align-items:center; justify-content:center; } .upgrade-modal-overlay.visible { display:flex; } .upgrade-modal { background:var(--bg-card); border:1px solid var(--border); border-radius:var(--radius-lg); padding:40px; max-width:420px; width:90%; text-align:center; } .upgrade-modal-icon { width:64px; height:64px; margin:0 auto 20px; background:linear-gradient(135deg,#f59e0b 0%,#ef4444 100%); border-radius:50%; display:flex; align-items:center; justify-content:center; } .upgrade-modal-icon svg { color:#fff; } .upgrade-modal h3 { font-size:1.25rem; margin-bottom:8px; color:var(--text-primary); } .upgrade-modal p { color:var(--text-secondary); margin-bottom:24px; font-size:0.9rem; line-height:1.6; } .upgrade-modal-actions { display:flex; gap:12px; } .upgrade-modal-actions a, .upgrade-modal-actions button { flex:1; padding:12px; border-radius:8px; font-size:0.85rem; font-weight:600; cursor:pointer; text-decoration:none; text-align:center; border:none; } .upgrade-modal .btn-dismiss { background:var(--bg-tertiary); color:var(--text-secondary); border:1px solid var(--border); } .upgrade-modal .btn-upgrade { background:linear-gradient(135deg,#f59e0b 0%,#ef4444 100%); color:#fff; }
  </style>
</head>
<body>
  <nav class="top-nav"><div class="nav-left"><a href="/" class="logo"><div class="logo-icon"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5"><path d="M12 2L2 7l10 5 10-5-10-5z"/><path d="M2 17l10 5 10-5"/><path d="M2 12l10 5 10-5"/></svg></div><span class="logo-text">MasteryPage</span></a>
    <div class="breadcrumb"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg><a href="../../textbook.html">Textbook</a><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg><a href="index.html">Domain 7</a><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg><span>Neurocognitive Disorders</span></div></div></nav>
  <div class="content-wrapper">
    <aside class="sidebar"><div class="sidebar-header"><div class="sidebar-title">Domain 7</div><div class="domain-title">Biopsychology</div></div>
      <ul class="chapter-list">
        <li class="chapter-item"><a href="index.html" class="chapter-link"><span class="chapter-number">0</span>Overview</a></li>
        <li class="chapter-item"><a href="brain-structure-lateralization.html" class="chapter-link"><span class="chapter-number">1</span>Brain Structure &amp; Lateralization</a></li>
        <li class="chapter-item"><a href="learning-encoding.html" class="chapter-link"><span class="chapter-number">2</span>Learning Processes &amp; Encoding Strategies</a></li>
        <li class="chapter-item"><a href="memory-architecture.html" class="chapter-link"><span class="chapter-number">3</span>Memory Architecture &amp; Working Memory</a></li>
        <li class="chapter-item"><a href="retrieval-forgetting.html" class="chapter-link"><span class="chapter-number">4</span>Retrieval, Forgetting &amp; Memory Distortion</a></li>
        <li class="chapter-item"><a href="neuroscience-memory.html" class="chapter-link"><span class="chapter-number">5</span>Neuroscience of Memory &amp; Amnesia</a></li>
        <li class="chapter-item"><a href="sleep-architecture.html" class="chapter-link"><span class="chapter-number">6</span>Sleep Architecture, Dreaming &amp; the Lifespan</a></li>
        <li class="chapter-item"><a href="neurons-neurotransmitters.html" class="chapter-link"><span class="chapter-number">7</span>Neurons, Neurotransmitters &amp; Neural Signaling</a></li>
        <li class="chapter-item"><a href="emotion-arousal.html" class="chapter-link"><span class="chapter-number">8</span>Emotion Theories, Arousal &amp; the ANS</a></li>
        <li class="chapter-item"><a href="sensation-perception.html" class="chapter-link"><span class="chapter-number">9</span>Sensation, Perception &amp; Psychophysics</a></li>
        <li class="chapter-item"><a href="neurodegenerative-movement.html" class="chapter-link"><span class="chapter-number">10</span>Neurodegenerative &amp; Movement Disorders</a></li>
        <li class="chapter-item"><a href="cerebrovascular-injury.html" class="chapter-link"><span class="chapter-number">11</span>Cerebrovascular Disease, Brain Injury &amp; Seizures</a></li>
        <li class="chapter-item"><a href="endocrine-neuroimaging.html" class="chapter-link"><span class="chapter-number">12</span>Endocrine Conditions, Neuroimaging &amp; Diagnostics</a></li>
        <li class="chapter-item"><a href="neurocognitive.html" class="chapter-link active"><span class="chapter-number">13</span>Neurocognitive Disorders</a></li>
      </ul>
    </aside>
    <main class="main-content">
      <div class="chapter-header"><div class="chapter-badge">Chapter 13 of 13</div><h1>Neurocognitive Disorders</h1><div class="chapter-meta"><span>Domain 7: Biopsychology</span><span>~30 min read</span></div></div>
      <div class="chapter-actions">
        <a href="javascript:void(0)" onclick="chapterAction('flashcards')" class="action-btn flashcard-btn"><svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><rect x="2" y="3" width="20" height="14" rx="2"/><line x1="8" y1="21" x2="16" y2="21"/><line x1="12" y1="17" x2="12" y2="21"/></svg>Flashcards</a>
        <a href="javascript:void(0)" onclick="chapterAction('quiz-fundamental', 7)" class="action-btn quiz-btn"><svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 11l3 3L22 4"/><path d="M21 12v7a2 2 0 01-2 2H5a2 2 0 01-2-2V5a2 2 0 012-2h11"/></svg>Quick Quiz: Fundamental</a>
        <a href="javascript:void(0)" onclick="chapterAction('advanced-learning', 7)" class="action-btn mastery-btn"><svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polygon points="12 2 15.09 8.26 22 9.27 17 14.14 18.18 21.02 12 17.77 5.82 21.02 7 14.14 2 9.27 8.91 8.26 12 2"/></svg>Advanced Learning</a>
      </div>

      <div class="content-section">
        <h2>DSM-5 Neurocognitive Disorder Framework</h2>
        <p>The DSM-5 replaced the older term "dementia" with <span class="key-term">neurocognitive disorder (NCD)</span>, organizing these conditions along a severity spectrum. This framework emphasizes that cognitive decline occurs on a continuum and recognizes multiple etiological subtypes.</p>
        <div class="definition-box">
          <strong>Major vs. Mild Neurocognitive Disorder:</strong>
          <p><span class="key-term">Major NCD</span> involves significant cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) that interferes with independence in everyday activities. <span class="key-term">Mild NCD</span> involves modest cognitive decline that does not interfere with independence in everyday activities, though greater effort, compensatory strategies, or accommodation may be needed. The distinction between major and mild NCD is primarily functional: can the person still manage daily activities independently?</p>
        </div>
        <p>The six cognitive domains assessed in the DSM-5 NCD framework are:</p>
        <table>
          <tr><th>Cognitive Domain</th><th>Examples of Assessment</th><th>Functional Impact When Impaired</th></tr>
          <tr><td>Complex Attention</td><td>Sustained attention, divided attention, selective attention, processing speed</td><td>Easily distracted, difficulty multitasking, cannot follow conversations in groups</td></tr>
          <tr><td>Executive Function</td><td>Planning, decision making, working memory, cognitive flexibility, error correction</td><td>Difficulty managing finances, making decisions, following complex instructions</td></tr>
          <tr><td>Learning &amp; Memory</td><td>Immediate memory, recent memory, long-term memory recall</td><td>Repeating questions, losing items, forgetting appointments and recent events</td></tr>
          <tr><td>Language</td><td>Expressive language, receptive language, word finding, grammar</td><td>Word-finding pauses, circumlocution, using general terms like "thing" or "it"</td></tr>
          <tr><td>Perceptual-Motor</td><td>Visual perception, visuoconstructional, praxis, gnosis</td><td>Getting lost in familiar places, difficulty using tools, trouble with spatial orientation</td></tr>
          <tr><td>Social Cognition</td><td>Emotion recognition, theory of mind, behavioral regulation</td><td>Socially inappropriate behavior, insensitivity to social cues, loss of empathy</td></tr>
        </table>
        <div class="citation">American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). The NCD framework replaced earlier "Dementia" and "Amnestic Disorders" categories.</div>
      </div>

      <div class="content-section">
        <h2>Alzheimer's Disease</h2>
        <p><span class="key-term">Alzheimer's disease (AD)</span> is the most common cause of major NCD, accounting for 60-80% of dementia cases. It is a progressive neurodegenerative disease characterized by insidious onset, gradual progression, and a characteristic neuropathological profile.</p>
        <div class="definition-box">
          <strong>Neuropathology:</strong>
          <p>The hallmark pathological features of AD are: (1) <span class="key-term">Amyloid plaques</span> (extracellular deposits of beta-amyloid protein), (2) <span class="key-term">Neurofibrillary tangles</span> (intracellular aggregates of hyperphosphorylated tau protein), and (3) Widespread neuronal loss and synaptic dysfunction. The pathology typically begins in the <span class="key-term">entorhinal cortex and hippocampus</span> (explaining the early memory symptoms) and progressively spreads to the temporal, parietal, and eventually frontal cortices. The <span class="key-term">cholinergic hypothesis</span> proposes that degeneration of cholinergic neurons in the nucleus basalis of Meynert, with resulting acetylcholine deficiency, is a primary contributor to cognitive decline. This is the basis for cholinesterase inhibitor treatment (donepezil, rivastigmine, galantamine).</p>
        </div>
        <h3>Clinical Course</h3>
        <ul>
          <li><strong>Early stage:</strong> Episodic memory impairment (forgetting recent events, repeating questions), word-finding difficulty, misplacing items, mild executive dysfunction. Procedural memory and remote memories are relatively preserved. Patients may show anosognosia (lack of awareness of deficits).</li>
          <li><strong>Middle stage:</strong> More pronounced memory loss (may not recognize family members), visuospatial disorientation (getting lost), language deterioration (fluent but empty speech), apraxia (difficulty with learned motor sequences), behavioral symptoms (agitation, wandering, sundowning, delusions of theft, paranoia).</li>
          <li><strong>Late stage:</strong> Severe cognitive decline across all domains, loss of ability to speak, walk, and swallow. Incontinence, bedbound state. Average duration from diagnosis to death is 8-10 years.</li>
        </ul>
        <div class="clinical-note">
          <strong>Risk Factors &amp; Genetics:</strong>
          <p>The <span class="key-term">APOE-e4 allele</span> is the strongest genetic risk factor for late-onset AD: one copy increases risk 3-4 fold; two copies increase risk 12-15 fold. However, APOE-e4 is a risk factor, not a deterministic gene -- not all carriers develop AD, and many AD patients lack the allele. Early-onset AD (before age 65, &lt;5% of cases) has stronger genetic determinism, linked to mutations in APP (amyloid precursor protein, chromosome 21), presenilin 1 (chromosome 14), and presenilin 2 (chromosome 1). The association with chromosome 21 explains the markedly elevated AD risk in Down syndrome (trisomy 21). Other modifiable risk factors include cardiovascular disease, diabetes, low education, social isolation, head injury, and hearing loss.</p>
        </div>
        <div class="example-box">
          <strong>EPPP Distinction &mdash; Cortical vs. Subcortical Dementia:</strong>
          <p>AD is the prototypical <span class="key-term">cortical dementia</span>, characterized by amnesia (hippocampal involvement), aphasia, agnosia, and apraxia (the "4 A's"). <span class="key-term">Subcortical dementias</span> (e.g., Parkinson's disease dementia, Huntington's disease) are characterized by psychomotor slowing, executive dysfunction, personality changes, and movement disorders, with relatively preserved language and recognition memory. Subcortical dementias show retrieval deficits (poor free recall but improved with cues), while cortical dementias show encoding/storage deficits (poor free recall AND cued recall). This distinction is heavily tested on the EPPP.</p>
        </div>
      </div>

      <div class="content-section">
        <h2>Vascular Neurocognitive Disorder</h2>
        <p><span class="key-term">Vascular NCD</span> (previously called vascular dementia or multi-infarct dementia) is the second most common cause of dementia, resulting from cerebrovascular disease. Unlike Alzheimer's, vascular NCD classically has a <span class="key-term">stepwise deterioration</span> rather than gradual decline, with each "step" corresponding to a new vascular event (stroke or TIA).</p>
        <ul>
          <li><strong>Multi-infarct dementia:</strong> Multiple large-vessel strokes producing cumulative cognitive damage. The cognitive profile depends on stroke locations.</li>
          <li><strong>Small vessel disease (subcortical vascular dementia):</strong> Chronic, progressive white matter ischemia (leukoaraiosis) producing executive dysfunction, psychomotor slowing, and gait abnormality. More gradual than multi-infarct type.</li>
          <li><strong>Strategic infarct dementia:</strong> A single stroke in a critical area (e.g., thalamus, angular gyrus, hippocampus) producing disproportionate cognitive impairment.</li>
        </ul>
        <div class="definition-box">
          <strong>Key Distinguishing Features:</strong>
          <p>Vascular NCD is distinguished from AD by: (1) temporal relationship to cerebrovascular events (onset within 3 months of stroke), (2) stepwise rather than gradual decline, (3) early executive dysfunction and psychomotor slowing (often more prominent than memory impairment), (4) focal neurological signs (hemiparesis, gait abnormality, pseudobulbar affect), (5) evidence of cerebrovascular disease on neuroimaging, and (6) vascular risk factors (hypertension, diabetes, hyperlipidemia, smoking, atrial fibrillation). Many patients have mixed dementia (both AD and vascular pathology), which the EPPP may test.</p>
        </div>
      </div>

      <div class="content-section">
        <h2>Lewy Body Disease &amp; Frontotemporal NCD</h2>
        <h3>NCD with Lewy Bodies</h3>
        <p><span class="key-term">Dementia with Lewy bodies (DLB)</span> is the third most common cause of dementia. Lewy bodies are intracellular inclusions composed of alpha-synuclein protein, found diffusely throughout the cortex and brainstem.</p>
        <div class="definition-box">
          <strong>Core Features of DLB:</strong>
          <p>The four core clinical features are: (1) <span class="key-term">Fluctuating cognition</span> with pronounced variations in attention and alertness (lucid intervals alternating with confused episodes), (2) <span class="key-term">Recurrent visual hallucinations</span> that are typically well-formed and detailed (e.g., seeing people, children, or animals that are not there), (3) <span class="key-term">REM sleep behavior disorder</span> (acting out dreams, which may precede cognitive symptoms by years), and (4) <span class="key-term">Spontaneous parkinsonism</span> (rigidity, bradykinesia, but tremor is less prominent than in Parkinson's disease). A critically important clinical feature: patients with DLB have <span class="key-term">severe neuroleptic sensitivity</span> -- conventional antipsychotics can cause life-threatening neuroleptic malignant syndrome or severe worsening. This is a high-yield EPPP fact.</p>
        </div>

        <h3>Frontotemporal NCD (Frontotemporal Dementia, FTD)</h3>
        <p><span class="key-term">Frontotemporal NCD</span> encompasses a group of disorders characterized by progressive degeneration of the frontal and/or temporal lobes. FTD typically has a younger onset than AD (often ages 45-65) and accounts for a significant proportion of early-onset dementias.</p>
        <table>
          <tr><th>Variant</th><th>Primary Lobe</th><th>Characteristic Features</th></tr>
          <tr><td><span class="key-term">Behavioral variant FTD (bvFTD)</span></td><td>Frontal (orbitofrontal, medial frontal)</td><td>Early, prominent personality change: disinhibition, apathy, loss of empathy, compulsive/ritualistic behaviors, dietary changes (hyperorality, sweet food preference), executive dysfunction. Memory and visuospatial function relatively preserved early on.</td></tr>
          <tr><td><span class="key-term">Semantic variant PPA</span></td><td>Anterior temporal (usually left)</td><td>Progressive loss of word meaning (semantic memory); fluent but empty speech; anomia; surface dyslexia (irregular word reading errors); may lose knowledge of objects and faces.</td></tr>
          <tr><td><span class="key-term">Nonfluent variant PPA</span></td><td>Left posterior frontal / insular</td><td>Effortful, halting speech; agrammatism; speech sound errors (apraxia of speech); relatively preserved word comprehension and object knowledge.</td></tr>
        </table>
        <div class="clinical-note">
          <strong>FTD vs. Alzheimer's on the EPPP:</strong>
          <p>The EPPP frequently tests the distinction between FTD and AD. Key differentiators: FTD has earlier onset (often before 65), personality/behavioral changes precede memory loss, memory and visuospatial skills are relatively preserved early on, and social cognition is disproportionately impaired. AD has later onset, memory impairment is the earliest and most prominent symptom, and personality is relatively preserved until later stages. Approximately 40% of FTD cases have a genetic component, with mutations in MAPT (tau), GRN (progranulin), and C9orf72 genes.</p>
        </div>
      </div>

      <div class="content-section">
        <h2>Delirium vs. Dementia</h2>
        <p>One of the most frequently tested EPPP differential diagnoses is <span class="key-term">delirium</span> versus <span class="key-term">dementia</span> (major NCD). Distinguishing these conditions is critical because delirium is a medical emergency that is often reversible when the underlying cause is treated.</p>
        <table>
          <tr><th>Feature</th><th>Delirium</th><th>Dementia (Major NCD)</th></tr>
          <tr><td>Onset</td><td>Acute (hours to days)</td><td>Insidious (months to years)</td></tr>
          <tr><td>Course</td><td>Fluctuating; worse at night (sundowning)</td><td>Progressive and relatively stable day-to-day</td></tr>
          <tr><td>Duration</td><td>Days to weeks (usually reversible)</td><td>Months to years (usually irreversible)</td></tr>
          <tr><td>Attention</td><td>Severely impaired (hallmark feature)</td><td>Relatively preserved until late stages</td></tr>
          <tr><td>Consciousness</td><td>Altered (clouded, fluctuating)</td><td>Clear until late stages</td></tr>
          <tr><td>Hallucinations</td><td>Common (especially visual)</td><td>Less common (except DLB)</td></tr>
          <tr><td>Psychomotor</td><td>Hyperactive, hypoactive, or mixed</td><td>Usually normal until late stages</td></tr>
          <tr><td>Reversibility</td><td>Usually reversible if cause treated</td><td>Usually irreversible (progressive)</td></tr>
        </table>
        <div class="example-box">
          <strong>Common Causes of Delirium (Mnemonic: I WATCH DEATH):</strong>
          <p><strong>I</strong>nfection, <strong>W</strong>ithdrawal (alcohol, benzodiazepines), <strong>A</strong>cute metabolic (electrolytes, hepatic/renal failure), <strong>T</strong>rauma/pain, <strong>C</strong>NS pathology (stroke, seizure), <strong>H</strong>ypoxia, <strong>D</strong>eficiencies (thiamine/B12), <strong>E</strong>ndocrine (thyroid, adrenal), <strong>A</strong>cute vascular (stroke, MI), <strong>T</strong>oxins/drugs (anticholinergics, opioids, benzodiazepines), <strong>H</strong>eavy metals. Anticholinergic medications are among the most common causes of drug-induced delirium, especially in elderly patients. Pre-existing dementia is itself a major risk factor for developing delirium.</p>
        </div>
      </div>

      <div class="content-section">
        <h2>Other Neurocognitive Disorders</h2>
        <h3>Creutzfeldt-Jakob Disease (CJD)</h3>
        <p><span class="key-term">Creutzfeldt-Jakob disease</span> is a rapidly progressive and fatal prion disease caused by misfolded prion proteins (PrPSc) that convert normal prion proteins to the pathogenic form. CJD produces rapidly progressive dementia (weeks to months, not years), myoclonus (sudden involuntary muscle jerks), and characteristic periodic sharp-wave complexes on EEG. The triad of rapidly progressive dementia, myoclonus, and periodic EEG changes is classic. Death typically occurs within one year of symptom onset. Variant CJD (vCJD) is linked to bovine spongiform encephalopathy ("mad cow disease") and tends to affect younger individuals.</p>

        <h3>HIV-Associated Neurocognitive Disorder (HAND)</h3>
        <p><span class="key-term">HIV-associated neurocognitive disorder</span> exists on a spectrum from asymptomatic neurocognitive impairment (ANI) to mild neurocognitive disorder (MND) to <span class="key-term">HIV-associated dementia (HAD)</span>. HIV preferentially targets subcortical structures (basal ganglia, white matter), producing a subcortical dementia profile: psychomotor slowing, executive dysfunction, and retrieval-based memory deficits. With effective antiretroviral therapy (ART), the incidence of HAD has dramatically decreased, though milder forms of HAND remain common.</p>

        <h3>Normal Pressure Hydrocephalus (NPH)</h3>
        <div class="definition-box">
          <strong>Normal Pressure Hydrocephalus:</strong>
          <p><span class="key-term">Normal pressure hydrocephalus (NPH)</span> is one of the few potentially reversible causes of dementia and is characterized by the classic triad of: (1) <span class="key-term">Gait disturbance</span> (magnetic gait -- wide-based, shuffling, as if feet are stuck to the floor; typically the first and most prominent symptom), (2) <span class="key-term">Urinary incontinence</span>, and (3) <span class="key-term">Dementia</span> (subcortical pattern with executive dysfunction and psychomotor slowing). The mnemonic is "wet, wobbly, and wacky." Neuroimaging shows ventriculomegaly (enlarged ventricles) disproportionate to cortical atrophy. Diagnosis is confirmed by improvement after a large-volume lumbar puncture (CSF tap test). Treatment is ventriculoperitoneal (VP) shunt placement. The EPPP emphasizes NPH as a reversible dementia that must not be missed.</p>
        </div>

        <h3>Substance/Medication-Induced NCD</h3>
        <p>Chronic alcohol use can produce <span class="key-term">Korsakoff syndrome</span> (thiamine/vitamin B1 deficiency leading to severe anterograde amnesia, confabulation, and apathy, with mammillary body and thalamic damage). The acute, reversible precursor is <span class="key-term">Wernicke encephalopathy</span> (confusion, ataxia, ophthalmoplegia) -- this is a medical emergency requiring immediate IV thiamine. Chronic inhalant abuse, chronic sedative use, and other substance use disorders can also produce persistent neurocognitive impairment.</p>
        <div class="citation">McKhann, G. M., et al. (2011). The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups. Alzheimer's &amp; Dementia, 7(3), 263-269.</div>
      </div>

      <div class="content-section">
        <h2>EPPP Exam Focus Points</h2>
        <ul>
          <li><strong>Major vs. mild NCD</strong>: The critical distinction is functional independence -- major NCD interferes with daily functioning; mild NCD does not</li>
          <li><strong>Alzheimer's disease</strong>: Most common dementia; amyloid plaques + neurofibrillary tangles; begins in hippocampus/entorhinal cortex; the "4 A's" (amnesia, aphasia, agnosia, apraxia)</li>
          <li><strong>APOE-e4</strong>: Strongest genetic risk factor for late-onset AD; one copy = 3-4x risk, two copies = 12-15x risk; risk factor, not deterministic</li>
          <li><strong>Cortical vs. subcortical dementia</strong>: Cortical (AD) = amnesia/aphasia/agnosia/apraxia, encoding deficit; Subcortical (Parkinson's, Huntington's) = slowed processing, executive dysfunction, retrieval deficit (improves with cues)</li>
          <li><strong>Vascular NCD</strong>: Stepwise decline, temporal relationship to strokes, early executive dysfunction, focal neurological signs, cerebrovascular risk factors</li>
          <li><strong>Lewy body dementia</strong>: Fluctuating cognition, vivid visual hallucinations, REM sleep behavior disorder, parkinsonism, <strong>SEVERE neuroleptic sensitivity</strong> (life-threatening)</li>
          <li><strong>Frontotemporal NCD</strong>: Earlier onset (45-65), personality/behavior changes before memory loss; behavioral variant = disinhibition/apathy; semantic PPA = loss of word meaning; nonfluent PPA = effortful speech</li>
          <li><strong>Delirium vs. dementia</strong>: Delirium = acute onset, fluctuating course, impaired attention/consciousness, usually reversible; Dementia = insidious onset, progressive, clear consciousness, usually irreversible</li>
          <li><strong>CJD</strong>: Rapid progressive dementia (weeks-months) + myoclonus + periodic sharp-wave EEG; prion disease; fatal within ~1 year</li>
          <li><strong>NPH</strong>: "Wet, wobbly, wacky" (incontinence, gait disturbance, dementia); reversible with VP shunt; ventriculomegaly on imaging</li>
          <li><strong>Wernicke-Korsakoff</strong>: Wernicke (acute: confusion, ataxia, ophthalmoplegia -- emergency IV thiamine); Korsakoff (chronic: anterograde amnesia, confabulation, mammillary bodies)</li>
          <li><strong>HIV-associated NCD</strong>: Subcortical profile (psychomotor slowing, executive dysfunction, retrieval deficits); dramatically decreased with ART</li>
        </ul>
      </div>

      <div class="nav-buttons">
        <a href="endocrine-neuroimaging.html" class="nav-btn"><span><div class="nav-btn-label">Previous</div><div class="nav-btn-title">Endocrine Conditions, Neuroimaging &amp; Diagnostics</div></span></a>
        <a href="index.html" class="nav-btn"><span><div class="nav-btn-label">Next</div><div class="nav-btn-title">Overview</div></span></a>
      </div>
    </main>
  </div>
  <div class="upgrade-modal-overlay" id="upgradeModal" onclick="if(event.target===this)this.classList.remove('visible')"><div class="upgrade-modal"><div class="upgrade-modal-icon"><svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polygon points="12 2 15.09 8.26 22 9.27 17 14.14 18.18 21.02 12 17.77 5.82 21.02 7 14.14 2 9.27 8.91 8.26 12 2"/></svg></div><h3>Upgrade to Unlock</h3><p>Flashcards, Quick Quizzes, and Mastery Quizzes are available on paid plans. Upgrade today to test your knowledge and track your progress.</p><div class="upgrade-modal-actions"><button class="btn-dismiss" onclick="document.getElementById('upgradeModal').classList.remove('visible')">Maybe Later</button><a href="../../index.html" class="btn-upgrade">View Plans</a></div></div></div>
  <script>function chapterAction(action, domainNum) { var tier = 'free'; try { var s = sessionStorage.getItem('passeppp_session'); if (s) { tier = JSON.parse(s).tier || 'free'; } } catch(e) {} if (tier === 'free') { document.getElementById('upgradeModal').classList.add('visible'); return; } if (action === 'flashcards') window.location.href = '../../index.html'; else if (action === 'quiz-fundamental') window.location.href = '../../index.html'; else if (action === 'advanced-learning') { var ch = document.querySelector('h1').textContent.trim(); window.location.href = '../../index.html'; } }</script>
</body>
</html>